Mortality and cancer incidence in acromegaly: A retrospective cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2730-2734

  Orme, Stephen M ^a,b   Mcnally, Richard J Q ^a   Cartwright, Ray A ^a   Belchetz, Paul E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ARTICLE; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; COLON CANCER; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACROMEGALY; BREAST NEOPLASMS; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0031759850     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2730     Document Type: Article

References (44)

1. Nabarro JDN. 1987 Acromegaly. Clin Endocrinol (Oxf). 26:481-512.
2. Pines A, Rozen P, Ron E, Gilat T. 1985 Gastrointestinal tumours in acromegalic patients. Am J Gastroenterol. 80:266-269.
3. Ron E, Gridley G, Hrubec Z, et al. 1991 Acromegaly and gastrointestinal cancer. Cancer. 68:1673-1677.
4. Barzilay J, Heatley GJ, Cushing GW. 1991 Benign and malignant tumours in patients with acromegaly. Arch Intern Med. 151:1629-1632.
5. Klein I, Pavneen G, Gavaler JS, et al. 1982 Colonic polyps in patients with acromegaly. Ann Intern Med. 97:21-30.
6. Ituarte EA, Petrini J, Hershman JM. 1984 Acromegaly and colon cancer. Ann Intern Med. 101:627-628.
7. Brunner JE, Cole Johnson C, Zafar S, et al. 1990 Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf). 32:65-71.
8. Ezzat S, Strom C, Melmed S. 1991 Colon polyps in acromegaly. Ann Intern Med. 114:754-755.
9. Jenkins PJ, Fairclough PD, Richards T, et al. 1997 Acromegaly colonic polyps and carcinoma. Clin Endocrinol (Oxf). 47:17-22.
10. Delhougne B, Deneux C, Abs R, et al. 1995 The prevalence of colonic polyps in acromegaly: a colonscopic and pathological study in 103 patients. J Clin Endocrinol Metab. 80:3223-3226.
11. Wright AD, Hill DM, Lowy C, Fraser TR. 1970 Mortality in acromegaly. Q J Med. 39:1-16.
12. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. 1980 Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf). 12:71-79.
13. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B. 1988 Epidemiology and long term survival in acromegaly. Acta Med Scand. 223:327-335.
14. Bates AS, Van't Hoff W, Jones JM, Clayton RN. 1993 An audit of outcome of treatment in acromegaly. Q J Med. 86:293-299.
15. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. 1994 Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf). 41:95-102.
16. Melmed S. 1990 Acromegaly. N Engl J Med. 322:966-977.
17. Bangham DR, Gaines Das RE, Schulster D. 1985 The International Standard for Human Growth Hormone for Bioassay: calibration and characterization by international collaborative study. Mol Cell Endocrinol. 42:269-282.
18. World Health Organization. 1978 ICD-9 Manual of the international statistical classification of diseases, 9th ed. Geneva: WHO.
19. Percy C, van Holten V, Muir C, eds. 1990 ICD-0 international classification of diseases for oncology, 2nd ed. Geneva: WHO.
20. Office of Population, Censuses, and Surveys. Mortality statistics; cause, England and Wales. Ser DH2, No. 1 (1974), No. 5 (1978), No. 10 (1983), No. 5 (1988), No. 20 (1993). London: HMSO.
21. Office of Population, Censuses, and Surveys. Mortality statistics; cause, England and Wales. Ser DH2, No. 1 (1974), No. 5 (1978), No. 10 (1983), No. 5 (1988), No. 20 (1993). London: HMSO.
22. Office of Population, Censuses, and Surveys. Mortality statistics; cause, England and Wales. Ser DH2, No. 1 (1974), No. 5 (1978), No. 10 (1983), No. 5 (1988), No. 20 (1993). London: HMSO.
23. Office of Population, Censuses, and Surveys. Mortality statistics; cause, England and Wales. Ser DH2, No. 1 (1974), No. 5 (1978), No. 10 (1983), No. 5 (1988), No. 20 (1993). London: HMSO.
24. Office of Population, Censuses, and Surveys. Mortality statistics; cause, England and Wales. Ser DH2, No. 1 (1974), No. 5 (1978), No. 10 (1983), No. 5 (1988), No. 20 (1993). London: HMSO.
25. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
26. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
27. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
28. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
29. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
30. Office of Population, Censuses, and Surveys. Cancer statistics: England, Wales, registration. Ser MB1, No. 1 (1971), No. 2 (1972-3), No. 10 (1978), No. 15 (1983), No. 21 (1988), No. 22 (1989). London: HMSO.
31. Coleman M, Douglas A, Hermon C. 1986 Cohort study analyses with a FORTRAN computer program. Int J Epidemiol. 15:134-137.
32. Breslow NE, Day NE. 1987 Statistical methods in cancer research, vol II. Lyon: IARC; 69-72.
33. McLellan AR, Connell JMC, Beastall GH, Teasdale G, Davies DL. 1988 Growth hormone, body composition and somatomedin-c after treatment of acromegaly. Q J Med. 69:997-1008.
34. Giovanelli MA, Motti EDF, Paracchi A, et al. 1976 Treatment of acromegaly by transsphenoidal microsurgery. J Neurosurg. 44:677-684.
35. Laws ER, Piepgras DG, Randali RV, et al. 1979 Neurosurgical management of acromegaly. J Neurosurg. 50:454-461.
36. Ho PJ, Jaffe CA, Friberg RD, et al. 1994 Persistence of rapid growth hormone (GH) pulsatility after the successful removal of GH-producing pituitary tumours. J Clin Endocrinol Metab. 78:1403-1410.
37. Ho KKY, Weissberger AJ. 1994 Characterization of 24 hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol (Oxf). 41:75-83.
38. Engholm G, Palmgren F, Lynge E. 1996 Lung cancer, smoking and environment: a cohort study of the Danish population. Br Med J. 312:1259-1263.
39. Chaffey CM, Bowie C. 1994 Radon and health - an update. J Public Health Med. 16:465-470.
40. Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P. 1994 Factors determining the long-term outcome of surgery for acromegaly. Q J Med. 87:617-623.
41. Feek CM, McLelland J, Seth J, et al. 1984 How effective is external pituitary irradiation for growth hormone-secreting pituitary tumours? Clin Endocrinol (Oxf). 20:401-408.
42. Vance ML, Harris AG. 1991 Long term treatment of 189 acromegalic patients with the somatostatin analogue octreotide: results of the International Multicentre Acromegaly Study Group. Arch Intern Med. 151:1573-1578.
43. Bevan JS, Webster J, Burke CW, Scanlon MF. 1992 Dopamine agonist and pituitary tumour shrinkage - a review. Endocr Rev. 13:220-240.
44. McGuffin WL, Sherman BM, Roth J, et al. 1974 Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med. 81:8-11.